September 21, 2012
Chugai Pharmaceutical announced on September 19 that it filed an application on the same day for an additional indication of recurrent glioblastoma for the anticancer agent Avastin (bevacizumab) with the Ministry of Health, Labor and Welfare (MHLW). The company was...read more